newsfilter
← Latest News
GlobeNewswire·

Aravive Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)

HOUSTON, June 13, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (NASDAQ:ARAV, "the Company")), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced that in